Creso Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Creso Pharma has a total shareholder equity of A$27.6M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$30.7M and A$3.2M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$3.14m |
| Equity | AU$27.59m |
| Total liabilities | AU$3.16m |
| Total assets | AU$30.75m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPHOA's short term assets (A$8.5M) exceed its short term liabilities (A$3.2M).
Long Term Liabilities: CPHOA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CPHOA is debt free.
Reducing Debt: CPHOA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CPHOA has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: CPHOA is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.